Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

Starting soon

Conditions studied: Diabetic Nephropathies

In brief

Study the relation between irisin level and progression of diabetic nephropathy and its early detection.

Key facts

Study ID

NCT07435480

Run by

Sohag University

People needed

200

Starts

2026-04-01

Expected to finish

2028-03-01

Last updated by the study team

2026-03-10

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetic patients

You may not qualify if…

• Non-diabetic kidney diseases.
• Acute illness, infection, obesity, hypertension, type 1 DM.
• Malignancy, other endocrine disorders, corticosteroid drugs, pregnancy, lactation.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.